Position in LLY
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$828,806
-$481,866 QoQ
Shares Held
691
-51.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#3,307
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TrueMark Investments, LLC holds $39,739,215 across 7 Drug Manufacturers - General names. LLY ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
50,803 | $12,902,437 | |
| 2 | ABBV |
AbbVie Inc.
|
37,043 | $9,321,500 | |
| 3 | GSK |
GSK plc
|
108,899 | $5,708,485 | |
| 4 | SNY |
Sanofi
|
125,869 | $5,369,571 | |
| 5 | AZN |
Astrazeneca PLC
|
18,998 | $3,602,400 | |
| 6 | NVS |
Novartis AG
|
12,800 | $2,006,016 | |
| 7 | LLY |
ELI LILLY & Co
This page
|
691 | $828,806 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $828,806 | 691 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,310,672 | 1,425 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $1,509,925 | 1,405 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,102,535 | 1,445 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $1,219,964 | 1,565 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,342,103 | 1,625 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,347,140 | 1,745 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,833,009 | 2,069 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $2,056,117 | 2,271 | Shares | Sole | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||